Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2005-07-19
2005-07-19
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
C568S018000, C568S027000, C568S037000, C564S340000, C562S040000, C562S405000, C562S400000, C560S030000, C560S040000
Reexamination Certificate
active
06919380
ABSTRACT:
Derivatives of C2-substituted indan-1-ol compounds of formula I:its physiologically acceptable salts, and its physiologically functional derivatives for the prophylaxis or treatment of obesity are disclosed herein. Compositions comprising the same, methods for preparing the instant compounds, and methods for reducing weight in mammals and for the prophylaxis or treatment of obesity are also described.
REFERENCES:
patent: 6717008 (2004-04-01), Jaehne et al.
patent: 0009554 (1980-04-01), None
patent: WO 97 20806 (1997-06-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 99/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 01/12176 (2001-02-01), None
patent: WO 01 62746 (2001-08-01), None
patent: WO 01 02373 (2002-01-01), None
CA:88:190435 abs of Journal of Organic Chemistry by Szmant et al 43(9) pp 1835-7 1978.
D. Edwards et al., “The Oxidation of Alkyl Sulphides”. J. Chemical Society, 1954, pp 3272-3284.
Ford, J.F., et al., “Stereochemistry of the Co-oxidation Products of Indene and Thiophenol.”Tetrahedron, vol. 4, 1958, pp. 325-336.
Lambert, P.D., et al., “Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity.”PNAS, vol. 98, No. 8, Apr. 10, 2001, pp. 4652-4657.
Maiti, A.K., et al., “Polyethylene Glycol (PEG) 4000 Catalysed Regioselective Nucleophilic Ring Opening of Oxiranes—A New and Convenient Synthesis ofβ-Hydroxy Sulfide.”Tetrahedron, vol. 50, No. 35, pp. 10483-10490.
Monteiro, Hugo J., et al., “A New Synthesis of β-Keto-Phenylsulfoxides.”Tetrahedron Letters, No. 11, 1975, pp. 921-924.
A. V. Sviridova et al., A Method for the Selective Oxidation . . . , Translated fromZhumal Organicheskoi Khimii,, vol. 7, No. 12, pp. 2480-2483, Dec., 1971, orginal Article submitted Dec. 21, 1970 (translated pages include 2577-2580).
Hugh W. Thompson., “Sterochemical Control of Reductions. The Directive Effect of Carbomethoxy vs. Hydroxymethyl Groups in Catalytic Hydrogenation” The Journal of Organic Chemistry 1971, pp 2577-2581.
Tyle, P., “Iontophoretic Devices for Drug Delivery.”Pharmaceutical Research, vol. 3, No. 6, 1986, pp. 318-326.
Venier, Clifford G., et al., “Peroxytrifluoroacetic Acid. A Convenient Reagent for the Preparation of Sulfoxides and Sulfones.”J. Or. Chem., vol. 47, 1982, pp. 3773-3774.
Seebach, Dieter, et al., “Herstellung α-thiolierter Carbonylverbindungen.”Chem. Ber., vol. 109, 1976, pp. 1601-1616.
Bickel Martin
Gossel Matthias
Jaehne Gerhard
Krone Volker
Aventis Pharma Deutschland GmbH.
Kurys Barbara E.
Nwaonicha Chukwuma
Richter Johann
LandOfFree
Derivatives of C2-substituted indan-1-ol systems for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of C2-substituted indan-1-ol systems for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of C2-substituted indan-1-ol systems for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367472